BNY compared with REGN: revenue, margins and what each company keeps, and the suppliers and customers both name

BNYBank of New York Mellon Corp

Mkt capRevenueRevenue

REGNRegeneron Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

BNYBank of New York Mellon Corp

REGNRegeneron Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BNY

2 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.1%▲+3.23%×1.03

Q2 FY26±2.8%▲+5.08%×1.82

Q1 FY26—▲+2.18%—

Jan 13 '26—▲+1.88%—

REGN

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.8%▲+13.33%×3.50

Q2 FY26±6.0%▲+6.17%×1.03

= impliedBNY realized, solidREGN realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

Q1 FY26

±6.0%

▼−6.21%

×1.03

Jan 30 '26±4.7%▼−1.07%×0.23

BNYBank of New York Mellon Corp

147.80▲+0.47%· post 147.88

Mkt cap$99.4BRevenue$5.7BQ3 FY26Revenue$20.1BFY25

REGNRegeneron Pharmaceuticals, Inc.

961.34▲+3.60%· post 966.48

ClosedNov 2 '26

Mkt cap$96.0BRevenue$5.1BQ3 FY26Revenue$14.3BFY25

Compare

ClosedNov 2 '26

BNYBank of New York Mellon Corp

REGNRegeneron Pharmaceuticals, Inc.

147.80▲+0.47%post 147.88

Price

961.34▲+3.60%post 966.48

$99.4B

Mkt cap

$96.0B

Q3 FY26$5.7B

Revenue

$5.1BQ3 FY26

FY25$20.1B

Revenue

$14.3BFY25

BNY147.80▲+0.47%vsREGN961.34▲+3.60%ClosedNov 2 '26